Coverage dated December 4, 2022 to December 7, 2022
FDA clears bivalent COVID-19 booster shots for children under 5
Headline from Fox2 Detroit, on the newest of 2 developments
The FDA has authorized use of the tweaked shots starting at age 6 months, but just who is eligible depends on how many vaccinations they’ve already had.
Fox2 Detroit's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Pfizer/BioNTech seek FDA authorization of updated Covid-19 vaccine for children under 5
Headline from Local News 8 ·
Newest
FDA clears bivalent COVID-19 booster shots for children under 5
By Jacqueline Howard, CNN Pfizer and BioNTech have submitted an application to the US Food and Drug Administration for their updated Covid-19 vaccine to be used as the third shot in the three-dose primary vaccine series for children ages 6 months through 4 years.
Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5. The youngest tots already are supposed to get three extra-small doses of the original
The FDA has authorized use of the tweaked shots starting at age 6 months, but just who is eligible depends on how many vaccinations they’ve already had.
U.S. regulators have cleared doses of the updated COVID-19 vaccines for children younger than 5. Omicron-targeted booster shots made by both Moderna and Pfizer already are urged for everyone 5
The FDA on Thursday approved the use of updated COVID-19 vaccines for children younger than 5, three days after Pfizer-BioNTech applied for an emergency use authorization.
The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.
The agency also cleared an updated shot of the coronavirus vaccine by Pfizer and its German partner, BioNTech, for children 6 months through 4 years old.
